Cargando…
A Novel Formulation of Cisplatin with γ-Polyglutamic Acid and Chitosan Reduces Its Adverse Renal Effects: An In Vitro and In Vivo Animal Study
Cisplatin (cis-diamminedichloroplatinum (II); CDDP) is a key chemotherapeutic agent but causes renal damage and other off-target effects. Here, we describe the pharmacological and biochemical characteristics of a novel formulation of CDDP complexed with γ-polyglutamic acid (γ-PGA) and chitosan (CS),...
Autores principales: | Sasai, Masao, Sakura, Kazuma, Matsuda, Takayuki, Uyama, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198433/ https://www.ncbi.nlm.nih.gov/pubmed/34070811 http://dx.doi.org/10.3390/polym13111803 |
Ejemplares similares
-
Non-Woven Sheet Containing Gemcitabine: Controlled Release Complex for Pancreatic Cancer Treatment
por: Sakura, Kazuma, et al.
Publicado: (2022) -
Stimulatory effects of amino acids on γ-polyglutamic acid production by Bacillus subtilis
por: Zhang, Chao, et al.
Publicado: (2018) -
Hydrocarbon Degradation and Microbial Survival Improvement in Response to γ-Polyglutamic Acid Application
por: Zając, Ewelina, et al.
Publicado: (2022) -
Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study
por: Sakura, Kazuma, et al.
Publicado: (2023) -
Cloning and Expression of the γ-Polyglutamic Acid Synthetase Gene pgsBCA in Bacillus subtilis WB600
por: Lin, Biaosheng, et al.
Publicado: (2016)